Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Stahel

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 4, 2012
Biomarker testing in non-small cell lung cancer: to move forward with qualityRolf Stahel
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Neoadjuvant chemotherapy in malignant pleural mesotheliomaRolf Stahel, Walter Weder
Translational Lung Cancer Research|March 26, 2015
Hippo/YAP pathway for targeted therapyEmanuela Felley-Bosco, Rolf Stahel
The Lancet. Oncology|February 13, 2016
Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power? - Authors' replyOliver Riesterer, Walter Weder, Rolf Stahel
Seminars in Thoracic and Cardiovascular Surgery|October 14, 2009
Multimodality strategies in malignant pleural mesotheliomaWalter Weder, Isabelle Opitz, Rolf Stahel
Cancer Treatment Reviews|November 21, 2017
PD-1 blockade in advanced NSCLC: A focus on pembrolizumabSolange Peters, Keith M Kerr, Rolf Stahel
Cancer Treatment Reviews|May 23, 2006
Cancer treatment reviews welcomes submission of the Cochrane ReviewsNicholas Pavlidis, Rolf Stahel, Mike Clarke, et al.
Expert Review of Anticancer Therapy|April 27, 2013
Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectivesJames A Lee, Lukas Bubendorf, Rolf Stahel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Ototoxicity in patients with dose-intensive therapy for cisplatin-resistant germ cell tumorsAdrian Dubs, Emanuel Jacky, Rolf Stahel, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2013
Treatment and detection of ALK-rearranged NSCLCSolange Peters, Miquel Taron, Lukas Bubendorf, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 4, 2012
Biomarker testing in non-small cell lung cancer: to move forward with qualityRolf Stahel
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Neoadjuvant chemotherapy in malignant pleural mesotheliomaRolf Stahel, Walter Weder
Translational Lung Cancer Research|March 26, 2015
Hippo/YAP pathway for targeted therapyEmanuela Felley-Bosco, Rolf Stahel
The Lancet. Oncology|February 13, 2016
Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power? - Authors' replyOliver Riesterer, Walter Weder, Rolf Stahel
Seminars in Thoracic and Cardiovascular Surgery|October 14, 2009
Multimodality strategies in malignant pleural mesotheliomaWalter Weder, Isabelle Opitz, Rolf Stahel
Cancer Treatment Reviews|November 21, 2017
PD-1 blockade in advanced NSCLC: A focus on pembrolizumabSolange Peters, Keith M Kerr, Rolf Stahel
Cancer Treatment Reviews|May 23, 2006
Cancer treatment reviews welcomes submission of the Cochrane ReviewsNicholas Pavlidis, Rolf Stahel, Mike Clarke, et al.
Expert Review of Anticancer Therapy|April 27, 2013
Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectivesJames A Lee, Lukas Bubendorf, Rolf Stahel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Ototoxicity in patients with dose-intensive therapy for cisplatin-resistant germ cell tumorsAdrian Dubs, Emanuel Jacky, Rolf Stahel, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2013
Treatment and detection of ALK-rearranged NSCLCSolange Peters, Miquel Taron, Lukas Bubendorf, et al.
Pageof 9